ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Styrax Tonkinensis

Also known as: Tonkin snowbell, Siam benzoin, Benzoin tree, Styrax hypoglaucus, Styrax tonkinensis

Overview

Styrax tonkinensis is a deciduous tree native to Southeast Asia, primarily Vietnam and southern China. Its main commercial product is the resin, known as benzoin, which exudes from the bark when injured. This resin has a long history of use in traditional Chinese medicine as an expectorant, antiseptic, and analgesic. It is typically applied topically or inhaled for respiratory conditions and pain relief. The tree itself can grow up to 25 meters tall. While the resin is also used in incense and perfumery, current interest in Styrax tonkinensis as a supplement focuses on its medicinal properties. Research into its efficacy and safety is still in early stages, with most studies being preclinical or ethnopharmacological, and a notable lack of high-quality human clinical trials.

Benefits

Based on traditional use and limited preclinical studies, Styrax tonkinensis resin (benzoin) is suggested to have potential benefits as an expectorant, antiseptic, and analgesic. In vitro and animal studies also indicate possible antioxidant, anti-inflammatory, and antimicrobial activities. However, these potential benefits lack rigorous clinical validation in humans. There are no human clinical trials with quantified outcomes, and therefore, no established effect sizes, clinical significance, or population-specific benefits. The strength of evidence is low, relying mainly on traditional reports and preliminary laboratory findings, with no systematic reviews or meta-analyses confirming these effects in humans.

How it works

The proposed mechanisms of action for Styrax tonkinensis resin involve the modulation of inflammatory pathways and direct antimicrobial effects. These actions are attributed to its phytochemical constituents, such as triterpenoids and lignans. Traditionally, it is believed to affect the respiratory and integumentary (skin) systems. In vitro studies suggest possible interactions with microbial membranes and inflammatory mediators. However, specific molecular targets have not been validated in humans, and human pharmacokinetic data regarding absorption and bioavailability are unavailable. Traditional use is primarily topical or inhalational, suggesting limited systemic absorption.

Side effects

Safety data for Styrax tonkinensis are primarily derived from traditional use, which generally reports good tolerability for external and inhalational applications. However, systemic toxicity is not well characterized due to a lack of clinical studies. There are no reported common, uncommon, or rare side effects from clinical trials. No documented drug interactions exist, though a theoretical risk of additive effects with other respiratory or analgesic agents is possible. Contraindications are not established, but individuals with known allergies to benzoin or related compounds should avoid its use. There is no safety data available for special populations such as pregnant or lactating women, or for pediatric use.

Dosage

The minimum effective dose, optimal dosage ranges, and maximum safe dose for Styrax tonkinensis are not established due to a lack of clinical research. Traditional preparations vary widely, and no standardized extract or dose has been clinically validated. Traditional use typically involves the resin (benzoin) in ointments, tinctures, or as incense. Oral use is rare and poorly documented. Timing considerations for administration are also not established, with traditional use generally being 'as needed' for symptom relief. Absorption is primarily through topical and inhalational routes, with systemic absorption likely minimal. No specific cofactors are identified as required for its efficacy.

FAQs

Is Styrax tonkinensis safe to use?

While traditional use suggests safety for external and inhalational applications, there is a lack of modern clinical data to assure systemic safety. Caution is advised due to unproven efficacy and safety in humans.

How should I use Styrax tonkinensis?

Traditional use involves the resin as an ingredient in ointments, tinctures, or inhaled as incense for symptom relief. There are no established guidelines for oral consumption or specific timing.

What benefits can I expect from Styrax tonkinensis?

Any potential benefits are based on traditional use and preclinical studies, suggesting roles as an expectorant, antiseptic, and analgesic. However, clinical efficacy in humans is unproven.

Is Styrax tonkinensis the same as other benzoin-producing trees?

No, Styrax tonkinensis is a distinct species. While it produces benzoin resin, it should not be conflated with other Styrax species like Styrax benzoin, as they differ botanically and chemically.

Research Sources

  • https://actascientific.com/ASAG/pdf/ASAG-06-1189.pdf – This narrative review by Mohammad Faizan et al. (2022) summarizes the traditional uses, phytochemistry, and limited preclinical data for various Styrax species, including S. tonkinensis. It highlights the resin's historical use in traditional medicine and its potential commercial value, but critically notes the significant absence of modern clinical research to validate its efficacy and safety in humans. The review relies on secondary sources and ethnopharmacological reports, providing no original data.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC10385552/ – This comprehensive review from Pharmaceuticals (Basel) (2023) examines the entire Styrax genus, detailing traditional uses, phytochemical constituents, and in vitro pharmacological activities such as antioxidant and antimicrobial properties. It identifies S. tonkinensis as a species of interest due to its chemical profile and traditional applications but explicitly underscores the complete absence of human clinical trials, emphasizing that current evidence is limited to preclinical and chemical data.
  • https://www.fao.org/4/ac776e/ac776e0a.htm – This FAO document provides general information about Styrax tonkinensis, focusing on its botanical characteristics, natural habitat, and the production of its resin. It describes the tree's growth, distribution in Southeast Asia, and the traditional method of resin collection. The document highlights the tree's economic importance, particularly for its aromatic resin, and its role in local economies, though it does not delve into specific medicinal research findings.